Tyvek 500 TYPT31SWHL0 datasheet

4. DuPont Personal Protection DuPont de Nemours (Luxembourg) S.àr.l. L-2984 Luxembourg Tel.: +800 3666 6666 (international toll-free) Fax: +352 3666 5071 E-mail: personal.protection@lux.dupont.com Important Note The permeation data published have been generated for DuPont by independent accredited testing laboratories according to the test method applicable at that time (EN369, ASTM F739, EN 374-3, EN ISO 6529 (method A and B) or ASTM D6978) The data is typically the average of three fabrics samples tested. All chemicals have been tested at an assay of greater than 95 (w/w) % unless otherwise stated. The tests were performed at room temperature and environmental pressure unless otherwise stated. A different temperature may have significant influence on the breakthrough time. Permeation typically increases with temperature. Cumulative permeation data have been measured or have been calculated based on steady state permeation rate. Cytostatic drugs testing has been performed at a test temperature of 27°C according to ASTM D6978 or ISO 6529 with the additional requirement of reporting a normalized breakthrough time at 0.01 μg/cm²/min. Chemical warfare agents (Lewisite, Sarin, Soman, Mustard, Tabun and VX Nerve Agent) have been tested according to MIL-STD-282 at 22°C or according to FINABEL 0.7 at 37°C. Permeation data for Tyvek® is applicable to white Tyvek® 500/ Tyvek® 600 only and is not applicable for other Tyvek® styles or colours. Permeation data are usually measured for single chemicals. The permeation characteristics of mixtures can often deviate considerably from the behaviour of the individual chemicals. Please use the permeation data provided as a part of the risk assessment to assist with the selection of a protective fabric, garment or accessory suitable for your application. Breakthrough time is not the same as safe wear time. Breakthrough times are indicative of the barrier performance, but results can vary between the test methods and laboratories. Breakthrough time alone is insufficient to determine how long a garment may be worn once the garment has been contaminated. Safe user wear time may be longer or shorter than the breakthrough time depending on the permeation behaviour of the substance, the toxicity of the substance, working conditions and the exposure conditions (e.g. temperature, pressure, concentration, physical state). Latest Update Permeation Data: 30/05/2018 Working in Ex-Zones: Please take this into account for your risk-assessment that accessories may not necessarily be grounded via the wearer/shoes and other measures for grounding the accessories and wearer may be required. Special consideration is required for overshoes, overboots which may isolate the wearer. This garment and/or fabric are not flame resistant and should not be used around heat, open flame, sparks or in potentially flammable environments. The information provided herein corresponds to our knowledge on the subject at the date of its publication. This information may be subject to revision as new knowledge and experience becomes available. The data provided fall within the normal range of product properties and relate only to the specific material designated; these data may not be valid for such material used in combination with any other materials or additives or in any process, unless expressly indicated otherwise. The data provided should not be used to establish specification limits or used alone as the basis of design; they are not intended to substitute for any testing you may need to conduct to determine for yourself the suitability of a specific material for your particular purposes. Since DuPont cannot anticipate all variations in actual end-use conditions DuPont makes no warranties and assumes no liability in connection with any use of this information. Nothing in this publication is to be considered as a license to operate under or a recommendation to infringe any patent rights. Technical_Description_1500_EN.pdf Printed on : July 2, 2018page of 4 4 For further product information, literature and as well as assistance in locating a local supplier, please visit: www.safespec.dupont.co.uk The footnotes can be found on the SafeSPEC™ website. Copyright © DuPont. All rights reserved. The DuPont Oval Logo, DuPont™, The miracles of science™ and all products denoted with ® or ™ are registered trademarks or trademarks of E. I. du Pont de Nemours and Company or its affiliates. Technical_Description_1500_EN.pdf Printed on : July 2, 2018

1. Product Description DuPont™ Tyvek® 500 Trousers model PT31L0. Elasticated waist. Stitched internal seams. No pockets. White. Certifications PPE Category I Antistatic treatment (EN 1149-5) - on both sides; see footnotes Packaging(Quantity/Box) 50 per box, bulk packed. CAT I Technical data sheet DuPont™ Tyvek® 500 Accessory , TYPT31SWHL0 Size Article Number Chest Girth(cm) Body Height(cm) Chest Girth(in) Body Height(ft/in) MD D13496109 92-100 168-176 36-39 5'6"-5'9" LG D13395741 100-108 174-182 39-43 5'8"-6'0" XL D13395735 108-116 180-188 43-46 5'11"-5'2" 2X D13496097 116-124 186-194 46-49 6'1"-6'4" Reference Number: TYPT31SWHL0 Technical_Description_1500_EN.pdf Printed on : July 2, 2018 page of 1 4

3. Permeation Data for Tyvek® 500 Hazard Name Physical State CAS BT Act BT 0.1 BT 1.0 EN SSPR MDPR Cum 480 Time 150 ISO Phosphoric acid (50%) Liquid 7664-38-2 >480 >480 >480 6 <0.005 0.005 <2.4 >480 6 Potassium chromate (sat) Liquid 7789-00-6 >480 >480 >480 6 <0.005 0.005 <2.4 >480 6 Potassium hydroxide (40%) Liquid 1310-58-3 60* 60* >480 6 0.7 0.001 Propane-1,2,3-triol Liquid 56-81-5 450 >480 >480 6 0.03 0.01 Sodium acetate (sat) Liquid 127-09-3 >480 >480 >480 6 <0.005 0.005 <2.4 >480 6 Sodium chloride (9 g/l) Liquid 7647-14-5 >240 >240 >240 5 <0.02 0.02 Sodium hydroxide (10%) Liquid 1310-73-2 >480 >480 >480 6 <0.005 0.005 <2.4 >480 6 Sodium hydroxide (40%) Liquid 1310-73-2 >480 >480 >480 6 <0.005 0.005 <2.4 >480 6 Sodium hydroxide (50%) Liquid 1310-73-2 10* 220* >480 6 0.85 0.01 Sodium hydroxide (>95%, solid) Solid 1310-73-2 >480 >480 >480 6 <0.01 0.01 <4.8 >480 6 Sodium hypochlorite (13%) Liquid 7681-52-9 >480 >480 >480 6 <0.005 0.005 <2.4 >480 6 Sodium hypochlorite (sat) Liquid 7681-52-9 >480 >480 >480 6 <0.01 0.01 <4.8 >480 6 Sulfuric acid (18%) Liquid 7664-93-9 >480 >480 >480 6 <0.005 0.005 <2.4 >480 6 Sulfuric acid (30%) Liquid 7664-93-9 >240 >240 >240 5 <0.005 0.005 Sulfuric acid (50%) Liquid 7664-93-9 10* 50* 75* 3 38 0.01 Sulfuric acid dimethyl ester Liquid 77-78-1 imm imm imm >160 0.02 Thiotepa (10 mg/ml) Liquid 52-24-4 <10 <10 <10 na 0.001 Vincristine sulfate (1 mg/ml) Liquid 2068-78-2 >240 >240 >240 5 <0.001 0.001 (Actual) Breakthrough time at MDPR [mins] BT Act Normalized breakthrough time at 0.1 μg/cm²/min [mins] BT 0.1 Normalized breakthrough time at 1.0 μg/cm²/min [mins] BT 1.0 Classification according to EN 14325 EN Steady state permeation rate [μg/cm²/min] SSPR Minimum detectable permeation rate [μg/cm²/min] MDPR Cumulative permeation mass after 480 mins [μg/cm²] CUM 480 Time to reach cumulative permeation Time 150 mass of 150 μg/cm² [mins] Classification according to ISO 16602 ISO Chemical abstracts service registry number CAS Minutes mins Larger than > Smaller than < Immediate (< 4 min) imm Not tested nm Saturated solution sat Not Applicable N/A Based on lowest single value * Not attained na Actual breakthrough time; normalized breakthrough time is not available 8 Technical_Description_1500_EN.pdf Printed on : July 2, 2018 page of 3 4

2. Permeation Data for Tyvek® 500 Hazard Name Physical State CAS BT Act BT 0.1 BT 1.0 EN SSPR MDPR Cum 480 Time 150 ISO Acetic acid (30%) Liquid 64-19-7 imm imm imm 13.5 0.001 Ammonium aqueous (16%) Liquid 1336-21-6 imm imm imm 20.3 0.005 Ammonium aqueous (30%) Liquid 1336-21-6 imm imm imm 16.7 0.014 Ammonium hydroxide (16%) Liquid 1336-21-6 imm imm imm 20.3 0.005 Ammonium hydroxide (30%) Liquid 1336-21-6 imm imm imm 16.7 0.014 Carboplatin (10mg/ml) Liquid 441575-94-4 >240 >240 >240 5 <0.001 0.001 Carmustine (3.3 mg/ml, 10 % Ethanol) Liquid 154-93-8 <10 <10 >240 5 <0.3 0.001 Caustic ammonia (16%) Liquid 1336-21-6 imm imm imm 20.3 0.005 Caustic ammonia (30%) Liquid 1336-21-6 imm imm imm 16.7 0.014 Caustic soda (10%) Liquid 1310-73-2 >480 >480 >480 6 <0.005 0.005 <2.4 >480 6 Caustic soda (40%) Liquid 1310-73-2 >480 >480 >480 6 <0.005 0.005 <2.4 >480 6 Caustic soda (50%) Liquid 1310-73-2 10* 220* >480 6 0.85 0.01 Caustic soda (>95%, solid) Solid 1310-73-2 >480 >480 >480 6 <0.01 0.01 <4.8 >480 6 Cisplatin (1 mg/ml) Liquid 15663-27-1 >240 >240 >240 5 <0.0002 0.0002 Cyclophosphamide (20 mg/ml) Liquid 50-18-0 >240 >240 >240 5 <0.002 0.002 Dimethyl sulfate Liquid 77-78-1 imm imm imm >160 0.02 Doxorubicin HCl (2 mg/ml) Liquid 25136-40-9 >240 >240 >240 5 <0.003 0.003 Ethane 1,2-diol Liquid 107-21-1 imm imm imm 6.6 0.002 Ethylene glycol Liquid 107-21-1 imm imm imm 6.6 0.002 Etoposide (Toposar®, Teva) (20 mg/ml, 33.2 % (v/v) Ethanol) Liquid 33419-42-0 >240 >240 >240 5 <0.01 <0.01 Fluorouracil, 5- (50 mg/ml) Liquid 51-21-8 <10 <10 47* 2 na 0.001 Formic acid (30%) Liquid 64-18-6 imm imm imm nm 0.001 Ganciclovir (3 mg/ml) Liquid 82410-32-0 >240 >240 >240 5 <0.005 0.005 Gemcitabine (38 mg/ml) Liquid 95058-81-4 <10 <60 >240 5 <0.4 0.005 Glycerine Liquid 56-81-5 450 >480 >480 6 0.03 0.01 Glycerol Liquid 56-81-5 450 >480 >480 6 0.03 0.01 Glycol alcohol Liquid 107-21-1 imm imm imm 6.6 0.002 Hydrochloric acid (16%) Liquid 7647-01-0 30* 60* 65* 3 11.1 0.005 Hydrochloric acid (30%) Liquid 7647-01-0 imm imm imm 10.1 0.01 Hydrogen peroxide (10%) Liquid 7722-84-1 >480 >480 >480 6 <0.01 0.01 <4.8 >480 6 Hydrogen peroxide (30%) Liquid 7722-84-1 imm* imm* nm >0.11 0.04 Ifosfamide (50 mg/ml) Liquid 3778-73-2 >240 >240 >240 5 <0.009 0.009 Irinotecan (20 mg/ml) Liquid 100286-90-6 imm* >240 >240 5 <0.1 0.0028 Mercuric II chloride (sat) Liquid 7487-94-7 >480 >480 >480 6 <0.01 0.01 <4.8 >480 6 Methotrexate (25 mg/ml, 0.1 N NaOH) Liquid 59-05-2 >240 >240 >240 5 <0.001 0.001 Mitomycin (0.5 mg/ml) Liquid 50-07-7 >240 >240 >240 5 <0.0009 0.0009 Nitric acid (10%) Liquid 7697-37-2 >480 >480 >480 6 <0.005 0.005 <2.4 >480 6 Nitric acid (30%) Liquid 7697-37-2 55 60* 60* 2 4.6 0.001 Oxaliplatin (5 mg/ml) Liquid 63121-00-6 <10 <10 <10 <0.1 0.006 (Actual) Breakthrough time at MDPR [mins] BT Act Normalized breakthrough time at 0.1 μg/cm²/min [mins] BT 0.1 Normalized breakthrough time at 1.0 μg/cm²/min [mins] BT 1.0 Classification according to EN 14325 EN Steady state permeation rate [μg/cm²/min] SSPR Minimum detectable permeation rate [μg/cm²/min] MDPR Cumulative permeation mass after 480 mins [μg/cm²] CUM 480 Time to reach cumulative permeation Time 150 mass of 150 μg/cm² [mins] Classification according to ISO 16602 ISO Chemical abstracts service registry number CAS Minutes mins Larger than > Smaller than < Immediate (< 4 min) imm Not tested nm Saturated solution sat Not Applicable N/A Based on lowest single value * Not attained na Actual breakthrough time; normalized breakthrough time is not available 8 Technical_Description_1500_EN.pdf Printed on : July 2, 2018 page of 2 4